A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2015 by Tocagen Inc.
Sponsor:
Information provided by (Responsible Party):
Tocagen Inc.
ClinicalTrials.gov Identifier:
NCT01156584
First received: July 1, 2010
Last updated: June 25, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2016
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)
No publications provided by Tocagen Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):